James Condulis
Stock Analyst at Stifel
(2.56)
# 2,303
Out of 4,896 analysts
5
Total ratings
50%
Success rate
23.42%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Condulis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NAMS NewAmsterdam Pharma Company | Initiates: Buy | $44 | $21.54 | +104.27% | 1 | Jun 10, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $74 → $108 | $81.57 | +32.41% | 2 | Mar 28, 2025 | |
| CYTK Cytokinetics | Initiates: Buy | $80 | $37.01 | +116.16% | 1 | Jan 22, 2025 | |
| EWTX Edgewise Therapeutics | Initiates: Hold | $30 | $13.85 | +116.61% | 1 | Jan 22, 2025 |
NewAmsterdam Pharma Company
Jun 10, 2025
Initiates: Buy
Price Target: $44
Current: $21.54
Upside: +104.27%
Soleno Therapeutics
Mar 28, 2025
Maintains: Buy
Price Target: $74 → $108
Current: $81.57
Upside: +32.41%
Cytokinetics
Jan 22, 2025
Initiates: Buy
Price Target: $80
Current: $37.01
Upside: +116.16%
Edgewise Therapeutics
Jan 22, 2025
Initiates: Hold
Price Target: $30
Current: $13.85
Upside: +116.61%